Posted on 01/12/2017 7:30:53 AM PST by Olog-hai
US president-elect Donald Trump has thrown down a major challenge to Ireland by using his first press conference since winning the White House to target the pharma and medtech sectors.
Hailing his recent success in persuading a number of major car manufacturers to route new investment into the United States rather than to Mexico under threat of substantial import tariffs, Mr. Trump turned his attention to drug manufacturers.
“We’ve got to get our drug industry back,” the incoming US president said. “Our drug industry has been disastrous. They’re leaving left and right. They supply our drugs, but they don’t make them here, to a large extent.”
Many US pharma companies have moved business out of the US in an effort to cut their tax bills. The incoming president has promised reform of corporate taxes to stem that tide. …
(Excerpt) Read more at irishtimes.com ...
The only solution to the problem is to take the ~$3.5 trillion “medical industry” and make it a $1 trillion a year industry by enforcing the Sherman, Clayton and Robinson-Patman acts against each and every actor in same.
Robinson-Patman, for example, states that any commodity (physical, standardized good) that travels in interstate or international commerce cannot have discriminatory pricing applied to it between buyers of like kind and quantity. This quite-clearly applies to drugs and supplies used in medical care
https://market-ticker.org/akcs-www?post=231763
Couple Law Enforcement with Disallowing FOREIGN Companies from using our Courts to defend their PATENTS and the GAME IS OVER for the Rampant Fraud in the Medical Industry.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.